If approved, Aphria says it expects Shoppers Drug Mart will sell Aphria-branded cannabis products online. (more…)
Tag Archives: Cannabis sector affecting pharmaceutical industry
Analysts have estimated that Epidiolex could be a $1 billion drug for GW Pharmaceuticals. (more…)
Many people have advocated using medical marijuana as an alternative for prescription opioids. But now researchers at the University of Florida will..
Anxiety disorders are the most common mental illness in the US. An estimated 40 million American adults, or just over 18%..
Hemp businesses are closely watching as the drug Epidiolex, made by GW Pharmaceuticals, moves through the FDA approval pipeline. (more…)
Many older adults use marijuana to help with chronic pain, an ailment that becomes more common with age. Others use..
Research into the potential medical uses of marijuana compounds continues apace. Among the most recent, a study delved into why..
Pharmaceutical companies are intrigued by the immense and growing medical marijuana market but cannot figure a way to corner it...
The largest survey on cannabidiol or CBD usage to date found that women were more likely than men to use..
Pharmaceutical companies developing cannabis-based products, and Israel-based companies developing and commercializing medicines with cannabis ingredients garner the most enthusiastic investment..
The report is intended to show how cannabis could disrupt pharmaceutical sales in key treatment areas including chronic pain, PTSD,..
